ArticleSignal transduction and targeted therapy2025

Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.

Lei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.